Triathlon® Cruciate Retaining (CR) Total Knee System Outcomes Study

NCT00957723 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 419

Last updated 2018-10-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the clinical outcomes (range of motion, pain, function, radiographic stability, and health related quality of life) of patients receiving the Triathlon® Cruciate Retaining (CR) Total Knee System. These outcomes will be evaluated by comparing pre-operative to post-operative scores, as well as to a control group. The control group is the Scorpio® CR Total Knee System.

Conditions

  • Arthroplasty, Replacement, Knee

Interventions

DEVICE

Triathlon® CR Total Knee System

The purpose is to evaluate the Triathlon® CR Total Knee System.

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Knute Buehler, MD · The Center: Orthopaedic & Neurosurgical Care & Research

  • Brian Covino, MD · Knoxville Orthopedic Clinic

  • Joseph Davies, MD · Aurora Advanced Healthcare

  • Kenneth Greene, MD · Crystal Clinic

  • Anthony Hedley, MD · Arizona Institute for Bone and Joint Disorders

  • Kirby Hitt, MD · Scott & White Memorial Hospital

  • Joseph McCarthy, MD · Newton-Wellesley Hospital

  • Jeffrey Nassif, MD · Physician's Clinic of Iowa, PC

  • Kenneth Krackow, MD · Buffalo General Hospital, Department of Orthopaedics

  • Sean Scully, MD · Cedars Medical Center University of Miami

  • Carlton Savory, MD · Hughston Sports Medicine Center

  • Mathew Phillips, MD · Buffalo General Hospital, Department of Orthopaedics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2010-04-30
Completion
2017-09-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00957723 on ClinicalTrials.gov